Pricing Log in Create free account
Saturday 17 October 2026 Export MDT’s income statement to Excel — free account

Medtronic PLC

MDT Healthcare Medical Devices

Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.

94.75 0.70 −0.73%
Market cap
$122.1B
P/E
23.2×
Fwd P/E
18.7×
Dividend yield
3.02%
F-score
7/9
Altman Z
2.73
Beneish M
−2.58
Dividend safety
61/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Medtronic PLC (MDT) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Sep 17, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jul 31, 2026 P1I2: 34 added · 37 removed · 74 modified
P2I1A: no comparison — the Item was not found
8-K Sep 1, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Apr 24, 2026 1: 7 added · 7 removed · 49 modified
1A: 16 added · 6 removed · 61 modified
7: 50 added · 39 removed · 77 modified
8-K Jun 3, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 18, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits Officer departure
8-K Apr 24, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 24, 2026 7.01 Regulation FD disclosure
10-Q Jan 23, 2026
8-K Feb 17, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Oct 24, 2025
8-K Nov 18, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Nov 1, 2025 5.02 Departure or appointment of directors or officers
8-K Oct 16, 2025 5.03 Amendments to the articles or bylaws; change in fiscal year; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
8-K Sep 29, 2025 1.01 Entry into a material definitive agreement; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Sep 15, 2025 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jul 25, 2025
10-K Apr 25, 2025

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.